Your browser doesn't support javascript.
loading
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
Li, Shuying S; Gilbert, Peter B; Carpp, Lindsay N; Pyo, Chul-Woo; Janes, Holly; Fong, Youyi; Shen, Xiaoying; Neidich, Scott D; Goodman, Derrick; deCamp, Allan; Cohen, Kristen W; Ferrari, Guido; Hammer, Scott M; Sobieszczyk, Magdalena E; Mulligan, Mark J; Buchbinder, Susan P; Keefer, Michael C; DeJesus, Edwin; Novak, Richard M; Frank, Ian; McElrath, M Juliana; Tomaras, Georgia D; Geraghty, Daniel E; Peng, Xinxia.
  • Li SS; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Carpp LN; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Pyo CW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Janes H; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Fong Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Shen X; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Neidich SD; Department of Biostatistics, University of Washington, Seattle, Washington, USA.
  • Goodman D; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
  • deCamp A; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
  • Cohen KW; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
  • Ferrari G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Hammer SM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Sobieszczyk ME; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
  • Mulligan MJ; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Buchbinder SP; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.
  • Keefer MC; Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, New York, USA.
  • DeJesus E; Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, New York, USA.
  • Novak RM; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
  • Frank I; Department of Medicine, University of California, San Francisco, California, USA.
  • McElrath MJ; Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
  • Tomaras GD; Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Geraghty DE; Orlando Immunology Center, Orlando, Florida, USA.
  • Peng X; University of Illinois at Chicago, Chicago, Illinois, USA.
J Virol ; 93(21)2019 11 01.
Article en En | MEDLINE | ID: mdl-31434737

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Infecciones por VIH / VIH-1 / Receptores de IgG / Vacunas de ADN / Polimorfismo de Nucleótido Simple Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfocitos B / Infecciones por VIH / VIH-1 / Receptores de IgG / Vacunas de ADN / Polimorfismo de Nucleótido Simple Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País como asunto: America do norte Idioma: En Año: 2019 Tipo del documento: Article